Clinical Trial Update: Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV) [NA]

View source ↗

Summary

A clinical trial (PANDA IV) is evaluating Probacine for protection against negative gut metabolism and organ dysfunction after cardiovascular surgery; enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Probacine (Probacine)

Snippet

Sponsor: Nanjing Medical University | Conditions: Cardiovascular Disease, Cardiopulmonary Bypass | NA | Status: ENROLLING_BY_INVITATION